ReproUnion
  • About
    • About Infertility
    • About ReproUnion
    • The Partners
    • Executive Board
    • Management Unit
    • PhD/postdoc project (2015-18)
    • Challenge concept (2019-22)
    • Publications
    • About ReproYoung
  • Innovation Platform
    • What is the Innovation Platform?
    • Collaboration
    • Innovation projects
    • Guidance: Inventions
  • Science
    • About Science
    • RUBIC Biobank
  • News
    • Latest News
      • 2025 News Archive
      • 2024 News Archive
      • 2023 News Archive
      • 2022 News Archive
      • 2021 News Archive
      • 2020 News Archive
      • 2019 News Archive
      • 2018 News Archive
      • 2017 News Archive
      • 2016 News Archive
      • 2015 News Archive
    • Spotlight Interviews
    • Media
      • 2025 Media Archive
      • 2024 Media Archive
      • 2023 Media Archive
      • 2022 Media archive
      • 2021 Media archive
      • 2020 Media archive
  • Events
    • Current Events
    • Previous Events
Select Page
RH LRB3: Growth activation of resting ovarian follicles – a novel approach for fertility treatment and preservation

RH LRB3: Growth activation of resting ovarian follicles – a novel approach for fertility treatment and preservation

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

 This study is performed by Susanne Pors at the Laboratory of Reproductive Biology, Rigshospitalet, Denmark, in collaboration with Clinical Chemistry, Lund University, Sweden. Based on new knowledge from this project it is the goal, in the future, to implement a new...
M1: Sperm DNA strand breaks in relation to infertility treatment and the health of the offspring Sperm

M1: Sperm DNA strand breaks in relation to infertility treatment and the health of the offspring Sperm

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

This study is performed at Malmø University Hospital at the Department of Growth and Reproduction in collaboration with several Danish fertility clinics. The gold standard in assessment of male reproductive function is standard semen analysis including evaluation of...
HOL2: MicroRNA as a biomarker for development of metabolic syndrome in women with Polycystic Ovary-Syndrome

HOL2: MicroRNA as a biomarker for development of metabolic syndrome in women with Polycystic Ovary-Syndrome

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

This study is performed at the Regional Fertility Clinic of Zealand in collaboration with Roskilde University Center. Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women and affects approximately 5-10%. Younger women with...
RH GR1: New method to quantify INSL3 by LC-MS/MS: A new diagnostic marker for Leydig cell function

RH GR1: New method to quantify INSL3 by LC-MS/MS: A new diagnostic marker for Leydig cell function

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

This study is performed at Department of Growth and Reproduction, Rigshospitalet, Denmark in collaboration with Lund University, Sweden. Insulin-like 3 (INSL3) is an insulin like hormone produced mainly in gonadal tissues in males (Leydig cells) and females. INSL3...
RH-FC2: Infertility and membrane fusion – The role of Syncytin in membrane fusion of human egg and sperm cells

RH-FC2: Infertility and membrane fusion – The role of Syncytin in membrane fusion of human egg and sperm cells

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

This study is performed at Rigshospitalet Fertility Clinic in collaboration with the fertility clinic in Malmø and University of Lund. Despite initial fertility assessments of couples seeking fertility treatment, approximately 5 % of couples referred to in vitro...
« Older Entries
Next Entries »
Our partners


Contact us



Linkedin



Youtube